Carregant...

Immunotherapy for the Treatment of Glioblastoma

Glioblastoma, the most aggressive primary brain tumor, thrives in a microenvironment of relative immunosuppression within the relatively immune-privileged central nervous system. Despite treatments with surgery, radiation therapy, and chemotherapy, prognosis remains poor. The recent success of immun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thomas, Alissa A., Ernstoff, Marc S., Fadul, Camilo E.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3269657/
https://ncbi.nlm.nih.gov/pubmed/22290259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3182431a73
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!